Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Contract Research & Services
Clinical Trials
Return to: PBR Home | Contract Research & Services | Clinical Trials

Clinical Trials

Otologic starts Phase I HNPN-1010 trial to treat hearing disorders By PBR Staff Writer
Otologic Pharmaceutics (OPI) has initiated a Phase I clinical trial of its lead product candidate HNPN-1010 to treat acute sensorineural hearing loss.
Contract Research & Services > Clinical Trials > News
Galena Biopharma closes enrollment in Phase II trial of GALE-401 By PBR Staff Writer
US-based Galena Biopharma has completed patient enrollment in the GALE-401, or Anagrelide Controlled Release, Phase II clinical trial to treat patients with elevated platelet counts in myeloproliferative neoplasms (MPNs).
Contract Research & Services > Clinical Trials > News CytRx gets FDA notice on partial clinical hold of aldoxorubicin clinical trials By PBR Staff Writer
US-based biopharmaceutical research and development firm CytRx has received notice from the US Food and Drug Administration (FDA) that its clinical trials for aldoxorubicin have been placed on partial clinical hold.
Contract Research & Services > Clinical Trials > News
See more Clinical Trials news

Latest Clinical Trials News and Insight

View all Clinical Trials news or find news targeted to your interests
Optional Modules and Services
With eClinicalOS (eCOS) from Merge eClinical, you can choose from a range of options to help you see your study more clearly — and manage it more smartly. Through our exclusive Clinical Confi gurator™, you simply click-andpick the capabilities that best fi t your research needs. So you get what you need — without having to pay for what you don’t.
Contract Research & Services > Clinical Trials > Case Studies
Product Brochure
There are phones, and then there are smart phones. There are cars, and then there are smart cars. There’s research, and now there’s smart research. That’s where we come in. Welcome to eClinicalOS.
Contract Research & Services > Clinical Trials > Case Studies
Galena Biopharma closes enrollment in Phase II trial of GALE-401
By PBR Staff Writer
US-based Galena Biopharma has completed patient enrollment in the GALE-401, or Anagrelide Controlled Release, Phase II clinical trial to treat patients with elevated platelet counts in myeloproliferative neoplasms (MPNs).
Contract Research & Services > Clinical Trials > News
CytRx gets FDA notice on partial clinical hold of aldoxorubicin clinical trials
By PBR Staff Writer
US-based biopharmaceutical research and development firm CytRx has received notice from the US Food and Drug Administration (FDA) that its clinical trials for aldoxorubicin have been placed on partial clinical hold.
Contract Research & Services > Clinical Trials > News
Merge eClinical - Where Smart Research Goes to Work
Merge eClinical develops and markets smart software that streamlines the clinical research process. Our company is built on the belief that every study – no matter its size, location or research setting – deserves the benefits offered by information technology to improve safety, quality and study outcomes. eClinicalOS™ (eCOS) is a single, scalable cloud-based platform that lets clinical research professionals design, launch and manage trials with more control, convenience and confidence than ever before. Eight of the top ten CROs and eight of the top ten pharmaceutical companies in the world use eCOS, and at least one new study using eCOS is deployed every day.
Contract Research & Services > Clinical Trials > Suppliers
Cortice Biosciences reports initial results from a Phase I/II trial of TPI 287 to treat recurrent Glioblastoma
Cortice Biosciences announced initial results from CB-017, a Phase 1/2 clinical trial evaluating TPI 287 plus bevacizumab (Avastin(R)) for the treatment of glioblastoma multiforme (GBM) that has recurred following front-line treatment.
Contract Research & Services > Clinical Trials > News
Merck reports positive Phase II trial results of melanoma drug pembrolizumab
By PBR Staff Writer
Merck has reported positive results from a pivotal Phase II trial (KEYNOTE-002) of its anti-PD-1 therapy pembrolizumab in patients with ipilimumab-refractory advanced melanoma.
Contract Research & Services > Clinical Trials > News
Woodley Equipment Company Announces the Appointment of Monika Hrdinkova
Woodley Equipment Company is pleased to announce the appointment of Monika Hrdinkova as office administrator working for our clinical trials division at our Hopkinton office near Boston, Massachusetts, US. Monika has extensive business management, customer service and logistics experience and Monika’s appointment will further strengthen the clinical trials customer service team.
Contract Research & Services > Clinical Trials > Press Releases
Bayer begins Phase II trial of riociguat to treat patients with dcSSc
By PBR Staff Writer
Bayer HealthCare has started a Phase II trial of riociguat to treat patients with diffuse cutaneous systemic sclerosis (dcSSc), the most severe form of systemic sclerosis (SSc).
Contract Research & Services > Clinical Trials > News
CASI gets China FDA nod to initiate Phase II trial of ENMD-2076 to treat soft tissue sarcoma
By PBR Staff Writer
CASI Pharmaceuticals has received approval from the China Food and Drug Administration (CFDA) to conduct a Phase II clinical trial with its proprietary drug candidate ENMD-2076 in soft tissue sarcoma patients in China.
Contract Research & Services > Clinical Trials > News
View all Clinical Trials news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250